Table of Contents

company-logo

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers Drewson, an anti-tumor biotherapeutic drug for the treatment of renal cancer, malignant melanoma, and cancerous thoracic and peritoneal effusion; and Xinde Lusheng for the treatment of kidney cancer, melanoma, lung cancer, gastric cancer, malignant lymphoma, breast cancer, ovarian tumor, bowel cancer, bladder cancer, head and neck tumor, leukemia and cancerous pleural effusion, etc. The company also provides Xin grain health, a recombinant human granulocyte colony stimulating factor injection; and Tourbo, a recombinant human erythropoietin injection for the treatment of anemia caused by renal insufficiency, including dialysis and non-dialysis patients. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.

Jiangsu Sihuan Bioengineering Dividend Announcement

• Jiangsu Sihuan Bioengineering announced a semi annually dividend of ¥0.06 per ordinary share which will be made payable on . Ex dividend date: 2003-08-26
• Jiangsu Sihuan Bioengineering 's trailing twelve-month (TTM) dividend yield is -%
• Jiangsu Sihuan Bioengineering 's payout ratio for the trailing twelve months (TTM) is -1.50%

Jiangsu Sihuan Bioengineering Dividend History

Ex-Div dateDividend amountDividend typePay date
2003-08-26¥0.06semi annually
2003-07-22¥0.01semi annually
2002-03-20¥0.03semi annually
2001-04-20¥0.04semi annually
1996-07-30¥0.01semi annually
1995-08-30¥0.03semi annually

Jiangsu Sihuan Bioengineering Dividend per year

Jiangsu Sihuan Bioengineering Dividend growth

Jiangsu Sihuan Bioengineering Dividend Yield

Jiangsu Sihuan Bioengineering current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Jiangsu Sihuan Bioengineering stock? Use our calculator to estimate your expected dividend yield:

Jiangsu Sihuan Bioengineering Financial Ratios

P/E ratio-84.45
PEG ratio-11.64
P/B ratio8.42
ROE-9.81%
Payout ratio-1.50%
Current ratio4.17
Quick ratio0.83
Cash Ratio0.12

Jiangsu Sihuan Bioengineering Dividend FAQ

Does Jiangsu Sihuan Bioengineering stock pay dividends?
Jiangsu Sihuan Bioengineering does not currently pay dividends to its shareholders.
Has Jiangsu Sihuan Bioengineering ever paid a dividend?
No, Jiangsu Sihuan Bioengineering has no a history of paying dividends to its shareholders. Jiangsu Sihuan Bioengineering is not known for its dividend payments.
Why doesn't Jiangsu Sihuan Bioengineering pay dividends?
There are several potential reasons why Jiangsu Sihuan Bioengineering would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Jiangsu Sihuan Bioengineering ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Jiangsu Sihuan Bioengineering has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Jiangsu Sihuan Bioengineering a dividend aristocrat?
Jiangsu Sihuan Bioengineering is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Jiangsu Sihuan Bioengineering a dividend king?
Jiangsu Sihuan Bioengineering is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Jiangsu Sihuan Bioengineering a dividend stock?
No, Jiangsu Sihuan Bioengineering is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Jiangsu Sihuan Bioengineering stocks?
To buy Jiangsu Sihuan Bioengineering you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Jiangsu Sihuan Bioengineering stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.